{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:34:27Z","timestamp":1772793267861,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The vaccine <jats:italic>Mycobacterium bovis<\/jats:italic> Bacillus Calmette-Gu\u00e9rin (BCG) elicits an immune response that is protective against certain forms of tuberculosis (TB); however, because BCG efficacy is limited it is important to identify alternative TB vaccine candidates. Recently, the BCG deletion mutant and vaccine candidate BCG\u0394BCG1419c was demonstrated to survive longer in intravenously infected BALB\/c mice due to enhanced biofilm formation, and better protected both BALB\/c and C57BL\/6 mice against TB-induced lung pathology during chronic stages of infection, relative to BCG controls. BCG\u0394BCG1419c-elicited protection also associated with lower levels of proinflammatory cytokines (i.e. IL6, TNF\u03b1) at the site of infection in C57BL\/6 mice. Given the distinct immune profiles of BCG- and BCG\u0394BCG1419c-immunized mice during chronic TB, we set out to determine if there are early immunological events which distinguish these two groups, using multi-dimensional flow cytometric analysis of the lungs and other tissues soon after immunization. Our results demonstrate a number of innate and adaptive response differences between BCG- and BCG\u0394BCG1419c-immunized mice which are consistent with the latter being longer lasting and potentially less inflammatory, including lower frequencies of exhausted CD4<jats:sup>+<\/jats:sup> T helper (T<jats:sub>H<\/jats:sub>) cells and higher frequencies of IL10-producing T cells, respectively. These studies suggest the use of BCG\u0394BCG1419c may be advantageous as an alternative TB vaccine candidate.<\/jats:p>","DOI":"10.1038\/s41598-022-14935-y","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T10:02:45Z","timestamp":1658397765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCG\u0394BCG1419c"],"prefix":"10.1038","volume":"12","author":[{"given":"Manuja","family":"Gunasena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni Kant","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiquan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Rosas Mejia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"Oestreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel de Jes\u00fas","family":"Aceves-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Alberto","family":"Flores-Valdez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namal P. M.","family":"Liyanage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"14935_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01910-17","author":"KM Guinn","year":"2017","unstructured":"Guinn, K. M. & Rubin, E. J. Tuberculosis: Just the FAQs. MBio https:\/\/doi.org\/10.1128\/mBio.01910-17 (2017).","journal-title":"MBio"},{"key":"14935_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-065X.2010.00984.x","volume":"240","author":"DG Russell","year":"2011","unstructured":"Russell, D. G. Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol. Rev. 240, 252\u2013268. https:\/\/doi.org\/10.1111\/j.1600-065X.2010.00984.x (2011).","journal-title":"Immunol. Rev."},{"key":"14935_CR3","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.4049\/jimmunol.1800993","volume":"201","author":"PL Lin","year":"2018","unstructured":"Lin, P. L. & Flynn, J. L. The end of the binary era: Revisiting the spectrum of tuberculosis. J. Immunol. 201, 2541\u20132548. https:\/\/doi.org\/10.4049\/jimmunol.1800993 (2018).","journal-title":"J. Immunol."},{"key":"14935_CR4","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/S0140-6736(12)60727-2","volume":"379","author":"M Raviglione","year":"2012","unstructured":"Raviglione, M. et al. Scaling up interventions to achieve global tuberculosis control: Progress and new developments. Lancet 379, 1902\u20131913. https:\/\/doi.org\/10.1016\/S0140-6736(12)60727-2 (2012).","journal-title":"Lancet"},{"key":"14935_CR5","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(18)32361-4","volume":"392","author":"B Marais","year":"2018","unstructured":"Marais, B. & Zumla, A. Advancing global tuberculosis control after the UNGA-HLM. Lancet 392, 1096\u20131097. https:\/\/doi.org\/10.1016\/S0140-6736(18)32361-4 (2018).","journal-title":"Lancet"},{"key":"14935_CR6","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","author":"BB Trunz","year":"2006","unstructured":"Trunz, B. B., Fine, P. & Dye, C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: A meta-analysis and assessment of cost-effectiveness. Lancet 367, 1173\u20131180. https:\/\/doi.org\/10.1016\/S0140-6736(06)68507-3 (2006).","journal-title":"Lancet"},{"key":"14935_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coi.2017.07.008","volume":"47","author":"AA Izzo","year":"2017","unstructured":"Izzo, A. A. Tuberculosis vaccines\u2014Perspectives from the NIH\/NIAID Mycobacteria vaccine testing program. Curr. Opin. Immunol. 47, 78\u201384. https:\/\/doi.org\/10.1016\/j.coi.2017.07.008 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"14935_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0003-2016","author":"T Lahey","year":"2016","unstructured":"Lahey, T. & von Reyn, C. F. Mycobacterium bovis BCG and new vaccines for the prevention of tuberculosis. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.TNMI7-0003-2016 (2016).","journal-title":"Microbiol. Spectr."},{"key":"14935_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.vaccine.2019.10.070","volume":"38","author":"MF Silveira","year":"2020","unstructured":"Silveira, M. F. et al. The emergence of vaccine hesitancy among upper-class Brazilians: Results from four birth cohorts, 1982\u20132015. Vaccine 38, 482\u2013488. https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.070 (2020).","journal-title":"Vaccine"},{"key":"14935_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4103\/ijcm.IJCM_351_18","volume":"44","author":"S Sankaranarayanan","year":"2019","unstructured":"Sankaranarayanan, S., Jayaraman, A. & Gopichandran, V. Assessment of vaccine hesitancy among parents of children between 1 and 5 years of age at a Tertiary Care Hospital in Chennai. Indian J. Community Med. 44, 394\u2013396. https:\/\/doi.org\/10.4103\/ijcm.IJCM_351_18 (2019).","journal-title":"Indian J. Community Med."},{"key":"14935_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/ijph.IJPH_397_17","volume":"62","author":"P Dasgupta","year":"2018","unstructured":"Dasgupta, P., Bhattacherjee, S., Mukherjee, A. & Dasgupta, S. Vaccine hesitancy for childhood vaccinations in slum areas of Siliguri, India. Indian J. Public Health 62, 253\u2013258. https:\/\/doi.org\/10.4103\/ijph.IJPH_397_17 (2018).","journal-title":"Indian J. Public Health"},{"key":"14935_CR12","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311X00011618","volume":"34","author":"AL Brown","year":"2018","unstructured":"Brown, A. L. et al. Vaccine confidence and hesitancy in Brazil. Cad Saude Publica 34, e00011618. https:\/\/doi.org\/10.1590\/0102-311X00011618 (2018).","journal-title":"Cad Saude Publica"},{"key":"14935_CR13","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1016\/j.vaccine.2016.08.035","volume":"34","author":"C Pedroza-Roldan","year":"2016","unstructured":"Pedroza-Roldan, C. et al. The BCGDeltaBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo. Vaccine 34, 4763\u20134770. https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.035 (2016).","journal-title":"Vaccine"},{"key":"14935_CR14","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.vaccine.2018.03.014","volume":"36","author":"CA Segura-Cerda","year":"2018","unstructured":"Segura-Cerda, C. A. et al. Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence. Vaccine 36, 2069\u20132078. https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.014 (2018).","journal-title":"Vaccine"},{"key":"14935_CR15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3389\/fmicb.2018.01281","volume":"9","author":"MA Flores-Valdez","year":"2018","unstructured":"Flores-Valdez, M. A. et al. The BCGDeltaBCG1419c vaccine candidate reduces lung pathology, IL-6, TNF-alpha, and IL-10 during chronic TB infection. Front. Microbiol. 9, 1281. https:\/\/doi.org\/10.3389\/fmicb.2018.01281 (2018).","journal-title":"Front. Microbiol."},{"key":"14935_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fimmu.2019.00532","volume":"10","author":"HD Sathkumara","year":"2019","unstructured":"Sathkumara, H. D. et al. BCG vaccination prevents reactivation of latent lymphatic murine tuberculosis independently of CD4(+) T cells. Front. Immunol. 10, 532. https:\/\/doi.org\/10.3389\/fimmu.2019.00532 (2019).","journal-title":"Front. Immunol."},{"key":"14935_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41541-020-0169-6","volume":"5","author":"CA Segura-Cerda","year":"2020","unstructured":"Segura-Cerda, C. A. et al. BCG and BCGDeltaBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines. NPJ Vaccines 5, 21. https:\/\/doi.org\/10.1038\/s41541-020-0169-6 (2020).","journal-title":"NPJ Vaccines"},{"key":"14935_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/fty088","author":"MJ Aceves-Sanchez","year":"2018","unstructured":"Aceves-Sanchez, M. J., Flores-Valdez, M. A., Shanley, C., Orme, I. & Bielefeldt-Ohmann, H. Vaccination of guinea pigs with BCGDeltaBCG1419c transiently reduces hematogenous spread of M. tuberculosis to the spleen. Pathog. Dis. https:\/\/doi.org\/10.1093\/femspd\/fty088 (2018).","journal-title":"Pathog. Dis."},{"key":"14935_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev.micro.61.080706.093426","volume":"61","author":"R Tamayo","year":"2007","unstructured":"Tamayo, R., Pratt, J. T. & Camilli, A. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu. Rev. Microbiol. 61, 131\u2013148. https:\/\/doi.org\/10.1146\/annurev.micro.61.080706.093426 (2007).","journal-title":"Annu. Rev. Microbiol."},{"key":"14935_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/iub.1353","volume":"67","author":"MA Flores-Valdez","year":"2015","unstructured":"Flores-Valdez, M. A. et al. The cyclic Di-GMP phosphodiesterase gene Rv1357c\/BCG1419c affects BCG pellicle production and in vivo maintenance. IUBMB Life 67, 129\u2013138. https:\/\/doi.org\/10.1002\/iub.1353 (2015).","journal-title":"IUBMB Life"},{"key":"14935_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00147-18","author":"N Noguchi","year":"2018","unstructured":"Noguchi, N. et al. Interleukin-21 induces short-lived effector CD8(+) T cells but does not inhibit their exhaustion after Mycobacterium bovis BCG infection in mice. Infect. Immun. https:\/\/doi.org\/10.1128\/IAI.00147-18 (2018).","journal-title":"Infect. Immun."},{"key":"14935_CR22","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/infdis\/jiy034","volume":"217","author":"P Paidipally","year":"2018","unstructured":"Paidipally, P. et al. Interleukin-21 regulates natural killer cell responses during Mycobacterium tuberculosis infection. J. Infect. Dis. 217, 1323\u20131333. https:\/\/doi.org\/10.1093\/infdis\/jiy034 (2018).","journal-title":"J. Infect. Dis."},{"key":"14935_CR23","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.4049\/jimmunol.1601231","volume":"199","author":"SS Cheekatla","year":"2017","unstructured":"Cheekatla, S. S. et al. IL-21 receptor signaling is essential for optimal CD4(+) T cell function and control of Mycobacterium tuberculosis infection in mice. J. Immunol. 199, 2815\u20132822. https:\/\/doi.org\/10.4049\/jimmunol.1601231 (2017).","journal-title":"J. Immunol."},{"key":"14935_CR24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3389\/fimmu.2020.01202","volume":"11","author":"TE Bickett","year":"2020","unstructured":"Bickett, T. E. et al. Characterizing the BCG induced macrophage and neutrophil mechanisms for defense against Mycobacterium tuberculosis. Front. Immunol. 11, 1202. https:\/\/doi.org\/10.3389\/fimmu.2020.01202 (2020).","journal-title":"Front. Immunol."},{"key":"14935_CR25","first-page":"529","volume":"55","author":"GP Youmans","year":"1947","unstructured":"Youmans, G. P. & Karlson, A. G. Streptomycin sensitivity of tubercle bacilli; studies on recently isolated tubercle bacilli and the development of resistance to streptomycin in vivo. Am. Rev. Tuberc. 55, 529\u2013535 (1947).","journal-title":"Am. Rev. Tuberc."},{"key":"14935_CR26","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1038\/s41467-018-07492-4","volume":"9","author":"G Xin","year":"2018","unstructured":"Xin, G. et al. Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection. Nat. Commun. 9, 5037. https:\/\/doi.org\/10.1038\/s41467-018-07492-4 (2018).","journal-title":"Nat. Commun."},{"key":"14935_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/eji.1830250211","volume":"25","author":"CH Ladel","year":"1995","unstructured":"Ladel, C. H., Daugelat, S. & Kaufmann, S. H. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: Contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25, 377\u2013384. https:\/\/doi.org\/10.1002\/eji.1830250211 (1995).","journal-title":"Eur. J. Immunol."},{"key":"14935_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/eji.1830250331","volume":"25","author":"CH Ladel","year":"1995","unstructured":"Ladel, C. H. et al. Contribution of alpha\/beta and gamma\/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: Studies with T cell receptor-deficient mutant mice. Eur. J. Immunol. 25, 838\u2013846. https:\/\/doi.org\/10.1002\/eji.1830250331 (1995).","journal-title":"Eur. J. Immunol."},{"key":"14935_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/eji.200839148","volume":"39","author":"PJ Maglione","year":"2009","unstructured":"Maglione, P. J. & Chan, J. How B cells shape the immune response against Mycobacterium tuberculosis. Eur. J. Immunol. 39, 676\u2013686. https:\/\/doi.org\/10.1002\/eji.200839148 (2009).","journal-title":"Eur. J. Immunol."},{"key":"14935_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fimmu.2017.00407","volume":"8","author":"JI Moliva","year":"2017","unstructured":"Moliva, J. I., Turner, J. & Torrelles, J. B. Immune responses to bacillus Calmette-Guerin vaccination: Why do they fail to protect against Mycobacterium tuberculosis?. Front. Immunol. 8, 407. https:\/\/doi.org\/10.3389\/fimmu.2017.00407 (2017).","journal-title":"Front. Immunol."},{"key":"14935_CR31","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1128\/IAI.73.11.7759-7764.2005","volume":"73","author":"A Kipnis","year":"2005","unstructured":"Kipnis, A., Irwin, S., Izzo, A. A., Basaraba, R. J. & Orme, I. M. Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) population. Infect. Immun. 73, 7759\u20137764. https:\/\/doi.org\/10.1128\/IAI.73.11.7759-7764.2005 (2005).","journal-title":"Infect. Immun."},{"key":"14935_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmi.2019.02.010","volume":"25","author":"MA Flores-Valdez","year":"2019","unstructured":"Flores-Valdez, M. A. New potential biomarkers to assess efficacy of protection afforded by vaccine candidates against tuberculosis. Clin. Microbiol. Infect. 25, 656\u2013658. https:\/\/doi.org\/10.1016\/j.cmi.2019.02.010 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"14935_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1128\/CVI.00721-14","volume":"22","author":"K Bhatt","year":"2015","unstructured":"Bhatt, K., Verma, S., Ellner, J. J. & Salgame, P. Quest for correlates of protection against tuberculosis. Clin. Vaccine Immunol. 22, 258\u2013266. https:\/\/doi.org\/10.1128\/CVI.00721-14 (2015).","journal-title":"Clin. Vaccine Immunol."},{"key":"14935_CR34","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.4049\/jimmunol.1201061","volume":"189","author":"JM Pitt","year":"2012","unstructured":"Pitt, J. M. et al. Blockade of IL-10 signaling during bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J. Immunol. 189, 4079\u20134087. https:\/\/doi.org\/10.4049\/jimmunol.1201061 (2012).","journal-title":"J. Immunol."},{"key":"14935_CR35","first-page":"53","volume":"8","author":"S Luca","year":"2013","unstructured":"Luca, S. & Mihaescu, T. History of BCG vaccine. Maedica (Buchar) 8, 53\u201358 (2013).","journal-title":"Maedica (Buchar)"},{"key":"14935_CR36","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","volume":"178","author":"GG Mahairas","year":"1996","unstructured":"Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C. & Stover, C. K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178, 1274\u20131282. https:\/\/doi.org\/10.1128\/jb.178.5.1274-1282.1996 (1996).","journal-title":"J. Bacteriol."},{"key":"14935_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","volume":"58","author":"P Mangtani","year":"2014","unstructured":"Mangtani, P. et al. Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials. Clin. Infect. Dis. 58, 470\u2013480. https:\/\/doi.org\/10.1093\/cid\/cit790 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"14935_CR38","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.1016\/j.vaccine.2021.11.038","volume":"39","author":"PJG Bettencourt","year":"2021","unstructured":"Bettencourt, P. J. G. et al. 100 years of the Bacillus Calmette-Guerin vaccine. Vaccine 39, 7221\u20137222. https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.038 (2021).","journal-title":"Vaccine"},{"key":"14935_CR39","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1080\/21645515.2016.1205769","volume":"12","author":"RC Harris","year":"2016","unstructured":"Harris, R. C., Sumner, T., Knight, G. M. & White, R. G. Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines. Hum. Vaccin. Immunother. 12, 2813\u20132832. https:\/\/doi.org\/10.1080\/21645515.2016.1205769 (2016).","journal-title":"Hum. Vaccin. Immunother."},{"key":"14935_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax4607","author":"RC Harris","year":"2020","unstructured":"Harris, R. C., Sumner, T., Knight, G. M., Zhang, H. & White, R. G. Potential impact of tuberculosis vaccines in China, South Africa, and India. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aax4607 (2020).","journal-title":"Sci. Transl. Med."},{"key":"14935_CR41","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.3389\/fmicb.2017.02651","volume":"8","author":"J Esteban","year":"2017","unstructured":"Esteban, J. & Garcia-Coca, M. Mycobacterium biofilms. Front. Microbiol. 8, 2651. https:\/\/doi.org\/10.3389\/fmicb.2017.02651 (2017).","journal-title":"Front. Microbiol."},{"key":"14935_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.15698\/mic2019.02.667","volume":"6","author":"P Chakraborty","year":"2019","unstructured":"Chakraborty, P. & Kumar, A. The extracellular matrix of mycobacterial biofilms: Could we shorten the treatment of mycobacterial infections?. Microb. Cell 6, 105\u2013122. https:\/\/doi.org\/10.15698\/mic2019.02.667 (2019).","journal-title":"Microb. Cell"},{"key":"14935_CR43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2005.09.012","volume":"123","author":"A Ojha","year":"2005","unstructured":"Ojha, A. et al. GroEL1: A dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell 123, 861\u2013873. https:\/\/doi.org\/10.1016\/j.cell.2005.09.012 (2005).","journal-title":"Cell"},{"key":"14935_CR44","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1038\/s41598-020-69152-2","volume":"10","author":"MA Flores-Valdez","year":"2020","unstructured":"Flores-Valdez, M. A. et al. Transcriptional portrait of M. bovis BCG during biofilm production shows genes differentially expressed during intercellular aggregation and substrate attachment. Sci. Rep. 10, 12578. https:\/\/doi.org\/10.1038\/s41598-020-69152-2 (2020).","journal-title":"Sci. Rep."},{"key":"14935_CR45","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1038\/ncomms11392","volume":"7","author":"A Trivedi","year":"2016","unstructured":"Trivedi, A., Mavi, P. S., Bhatt, D. & Kumar, A. Thiol reductive stress induces cellulose-anchored biofilm formation in Mycobacterium tuberculosis. Nat. Commun. 7, 11392. https:\/\/doi.org\/10.1038\/ncomms11392 (2016).","journal-title":"Nat. Commun."},{"key":"14935_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/2049-632X.12144","volume":"70","author":"DF Ackart","year":"2014","unstructured":"Ackart, D. F. et al. Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis. Pathog. Dis. 70, 359\u2013369. https:\/\/doi.org\/10.1111\/2049-632X.12144 (2014).","journal-title":"Pathog. Dis."},{"key":"14935_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2958.2008.06274.x","volume":"69","author":"AK Ojha","year":"2008","unstructured":"Ojha, A. K. et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 69, 164\u2013174. https:\/\/doi.org\/10.1111\/j.1365-2958.2008.06274.x (2008).","journal-title":"Mol. Microbiol."},{"key":"14935_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fmicb.2016.00014","volume":"7","author":"MA Flores-Valdez","year":"2016","unstructured":"Flores-Valdez, M. A. Vaccines directed against microorganisms or their products present during biofilm lifestyle: Can we make a translation as a broad biological model to tuberculosis?. Front. Microbiol. 7, 14. https:\/\/doi.org\/10.3389\/fmicb.2016.00014 (2016).","journal-title":"Front. Microbiol."},{"key":"14935_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrmicro2109","volume":"7","author":"R Hengge","year":"2009","unstructured":"Hengge, R. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol. 7, 263\u2013273. https:\/\/doi.org\/10.1038\/nrmicro2109 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"14935_CR50","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nature10429","volume":"478","author":"DL Burdette","year":"2011","unstructured":"Burdette, D. L. et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478, 515\u2013518. https:\/\/doi.org\/10.1038\/nature10429 (2011).","journal-title":"Nature"},{"key":"14935_CR51","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1084\/jem.20082874","volume":"206","author":"SM McWhirter","year":"2009","unstructured":"McWhirter, S. M. et al. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J. Exp. Med. 206, 1899\u20131911. https:\/\/doi.org\/10.1084\/jem.20082874 (2009).","journal-title":"J. Exp. Med."},{"key":"14935_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/2051013613501988","volume":"1","author":"TW Dubensky Jr","year":"2013","unstructured":"Dubensky, T. W. Jr., Kanne, D. B. & Leong, M. L. Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants. Ther. Adv. Vaccines 1, 131\u2013143. https:\/\/doi.org\/10.1177\/2051013613501988 (2013).","journal-title":"Ther. Adv. Vaccines"},{"key":"14935_CR53","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.1244040","volume":"341","author":"XD Li","year":"2013","unstructured":"Li, X. D. et al. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341, 1390\u20131394. https:\/\/doi.org\/10.1126\/science.1244040 (2013).","journal-title":"Science"},{"key":"14935_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa070","author":"JB Velazquez-Fernandez","year":"2021","unstructured":"Velazquez-Fernandez, J. B. et al. Proteomic characterization of a second-generation version of the BCGDeltaBCG1419c vaccine candidate by means of electrospray-ionization quadrupole time-of-flight mass spectrometry. Pathog. Dis. https:\/\/doi.org\/10.1093\/femspd\/ftaa070 (2021).","journal-title":"Pathog. Dis."},{"key":"14935_CR55","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.1038\/s41598-021-91993-8","volume":"11","author":"MJ Aceves-Sanchez","year":"2021","unstructured":"Aceves-Sanchez, M. J. et al. Vaccination with BCGDeltaBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG. Sci. Rep. 11, 12417. https:\/\/doi.org\/10.1038\/s41598-021-91993-8 (2021).","journal-title":"Sci. Rep."},{"key":"14935_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/imm.12010","volume":"138","author":"K Bobadilla","year":"2013","unstructured":"Bobadilla, K. et al. Human phagosome processing of Mycobacterium tuberculosis antigens is modulated by interferon-gamma and interleukin-10. Immunology 138, 34\u201346. https:\/\/doi.org\/10.1111\/imm.12010 (2013).","journal-title":"Immunology"},{"key":"14935_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1365-2249.2004.02577.x","volume":"138","author":"S de la Barrera","year":"2004","unstructured":"de la Barrera, S. et al. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin. Exp. Immunol. 138, 128\u2013138. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02577.x (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"14935_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1046\/j.1365-2567.2000.00018.x","volume":"99","author":"L Faulkner","year":"2000","unstructured":"Faulkner, L., Buchan, G. & Baird, M. Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation. Immunology 99, 523\u2013531. https:\/\/doi.org\/10.1046\/j.1365-2567.2000.00018.x (2000).","journal-title":"Immunology"},{"key":"14935_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cyto.2017.05.015","volume":"97","author":"RT Robinson","year":"2017","unstructured":"Robinson, R. T. & Huppler, A. R. The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers. Cytokine 97, 49\u201365. https:\/\/doi.org\/10.1016\/j.cyto.2017.05.015 (2017).","journal-title":"Cytokine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14935-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:17:39Z","timestamp":1669349859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14935"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14935-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12377"}}